Piroxicam

A to Z Drug Facts

Piroxicam

  Action
  Indications
  Contraindications
  Route/Dosage
  Interactions
  Lab Test Interferences
  Adverse Reactions
  Precautions
Patient Care Considerations
  Administration/Storage
  Assessment/Interventions
  Patient/Family Education


(pihr-OX-ih-kam)
Feldene,  Alti-Piroxicam, Apo-Piroxicam, Gen-Piroxicam, Novo-Pirocam, Nu-Pirox
Class: Analgesic/NSAID

 Action Decreases inflammation, pain and fever, probably through inhibition of cyclooxygenase activity and prostaglandin synthesis.

 Indications Treatment of acute or long-term use of rheumatoid arthritis and osteoarthritis. Unlabeled use(s): Symptomatic relief of primary dysmenorrhea, pain, sunburn, juvenile rheumatoid arthritis.

 Contraindications Known allergy or hypersensitivity to aspirin, iodides or any NSAID, including piroxicam.

 Route/Dosage

Rheumatoid Arthritis, Osteoarthritis

ADULTS: PO Initiate and maintain at 20 mg/day in 1 to 2 divided doses.

 Interactions

Alcohol: May augment risk of GI bleeding. Anticoagulants: May increase effect of anticoagulants due to decreased plasma protein binding and inhibition of platelet aggregation. May increase risk of gastric erosion and bleeding. Beta-blockers: Antihypertensive effect may be decreased. Cholestyramine: Effects of piroxicam may be decreased. Lithium: May decrease lithium clearance. Methotrexate: May increase methotrexate levels and methotrexate toxicity. Ritonivir: May increase concentrations and possibly the toxicity of piroxicam by inhibiting its metabolism.

 Lab Test Interferences May prolong bleeding time. May reversibly increase BUN and serum creatinine.

 Adverse Reactions

CV: Edema; weight gain; CHF; alterations in BP; vasodilation; palpitations; tachycardia. CNS: Headache; malaise; dizziness; somnolence; vertigo; depression; insomnia; nervousness. DERM: Pruritus; rash; sweating; erythema; bruising; desquamation; erythema multiforme; toxic epidermal necrolysis. EENT: Tinnitus; swollen eyes; blurred vision; eye irritation; rhinitis; pharyngitis. GI: Epigastric distress; nausea; vomiting; anorexia; constipation; stomatitis; abdominal discomfort; diarrhea; flatulence; abdominal pain; indigestion; toxicity (bleeding, ulceration, perforation); heartburn; dyspepsia; anorexia. GU: Hematuria; proteinuria; increased BUN and serum creatinine; acute renal insufficiency and failure; papillary necrosis; interstitial nephritis; nephrotic syndrome; hyperkalemia; hyponatremia. HEMA: Increased bleeding time; decreased Hgb and Hct; anemia; leukopenia; eosinophilia, thrombocytopenia. HEPA: Increased liver function tests; elevated liver enzymes. RESP: Bronchospasm; laryngeal edema; dyspnea; hemoptysis; shortness of breath.

 Precautions

Pregnancy: Category C. Lactation: Undetermined. Children: Safety and efficacy not established. Elderly: Increased risk of adverse reactions. May require decreased dosage. Asthma: In certain patients (aspirin-allergic, nasal polyps) may precipitate asthma attacks. Cardiovascular disease: May worsen CHF and hypertension. Coagulation disorders: Increases risk of bleeding. Dermatologic effects: Combination of dermatologic/allergic signs and symptoms (ie, arthralgias, pruritus, fever, fatigue, rash including vesiculobullous reactions, exfoliative dermatitis) suggestive of serum sickness have occurred. GI effects: Serious GI toxicity can occur at any time, with or without warning symptoms. Renal disease: Drug may accumulate, increasing the risk of toxicity. In cases of advanced kidney disease, treatment with piroxicam is not recommended.


PATIENT CARE CONSIDERATIONS


 Administration/Storage

 Assessment/Interventions

OVERDOSAGE: SIGNS & SYMPTOMS
  Drowsiness, dizziness, mental confusion, disorientation, lethargy, paresthesia, numbness, vomiting, GI irritation, headache, tinnitus, seizure, increased BUN

 Patient/Family Education

Books@Ovid
Copyright
© 2003 Facts and Comparisons
David S. Tatro
A to Z Drug Facts